References
- Marshall B J. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116–28
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65–9
- Mobley H LT, Hu L-T, Foxall P A. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol 1991, Suppl 187: 39–46
- Slomiany B L, Bilski J, Sarosiek J, et al. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987; 144: 307–14
- Slomiany B L, Kasinathan C, Slomiany A. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol). Am J Gastroenterol 1989; 84: 1273–7
- Leunk R D, Johnson P T, David B C, Kraft W G, Morgan D R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93–9
- Figura N, Gugllelmetti A, Rossollnl A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225–6
- Cover T L, Dooley C P, Blaser M J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603–10
- Davies G R, Simmonds N J, Stevens T RJ, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179–85
- Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielsson D. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599–603
- Graham D Y, Go M F. Helicobacter pylori: current status. Gastroenterology 1993; 105: 279–82
- Reid M F, Fewson C A. Molecular characterization of microbial alcohol dehydrogenases. Crit Rev Microbiol 1994; 20: 13–56
- Klipstein F A, Holdeman L V, Corcino J J, Moore W EC. Enterotoxigenic intestinal bacteria in tropical sprue. Ann Int Med 1973; 79: 632–41
- Mezey E, Imbembo A L, Potter J J, Rent K C, Lombardo R, Holt P R. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am J Clin Nutr 1975; 28: 1277–83
- Bode J C, Rust S, Bode C. The effect of cimetidine treatment on ethanol formation in the human stomach. Scand J Gastroenterol 1984; 19: 853–6
- Baraona E, Julkunen R, Tannenbaum L, Lieber C S. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986; 90: 103–10
- Pikkarainen P H, Baraona E, Jauhonen P, Seitz H K, Lieber C S. Contribution of oropharynx microflora and of lung microsomes to acetaldehyde in expired air after alcohol ingestion. J Lab Clin Med 1981; 97: 631–6
- Miyakawa H, Baraona E, Chang J C, Lesser M D, Lieber C S. Oxidation of ethanol to acetaldehyde by bronchopulmonary washings: role of bacteria. Alcohol Clin Exp Res 1986; 10: 517–20
- Jokelainen K, Roine R P, Väänänen H, Färkkilä M, Salaspuro M. In vitro acetaldehyde formation by human colonic bacteria. Gut 1994; 35: 1271–4
- Roine R P, Salmela K S, Höök-Nikanne J, Kosunen T U, Salaspuro M. Alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori- a possible mechanism behind gastric injury. Life Sci 1992; 51: 1333–7
- Salmela K S, Roine R P, Koivisto T, Höök-Nikanne J, Kosunen T U, Salaspuro M. Characteristics of Helicobacter pylori alcohol dehydrogenase. Gastroenterology 1993; 105: 325–30
- Roine R P, Salmela K S, Höök-Nikanne J, Kosunen T U, Salaspuro M. Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori. Life Sci 1992; 51: PL195–200
- Salmela K S, Roine R P, Höök-Nikanne J, Kosunen T U, Salaspuro M. Acetaldehyde and ethanol production by Helicobacter pylori. Scand J Gastroenterol 1994; 29: 309–12
- Salmela K S, Salaspuro M, Gentry R T, et al. Helicobacter infection and gastric ethanol metabolism. Alcohol Clin Exp Res 1994; 18: 1294–9
- Sorrell M F, Tuma D J. The functional implications of acetaldehyde binding to cell constituents. Ann NY Acad Sci 1987; 492: 50–62
- Sillanaukee P, Koivula T. Detection of a new acetaldehyde-induced hemoglobin fraction HbA27. J Clin Invest 1991; 87: 1367–74, Niemelä O, Juvonen T Parkkila S Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption
- Holstege A, Bedossa P, Poynard T, et al. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. Hepatology 1994; 19: 367–74
- Mauch T J, Donohue T M, Jr, Zetterman R K, Sorrell M F, Tuma D J. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes. Hepatology 1986; 6: 263–9
- Tuma D J, Jennett R B, Sorrell M F. The interaction of acetaldehyde with tubulin. Ann NY Acad Sci 1987; 492: 277–86
- Niemelä O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987; 7: 1210–4
- Tuma D J, Klassen L W. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 1992; 103: 1969–73
- Yokoyama H, Ishii H, Nagata S, Kato S, Kamegaya K, Tsuchlya M. Experimental hepatitis induced by ethanol after immununization with acetaldehyde adducts. Hepatology 1993; 17: 14–9
- Lieber C S, Leo M A. Alcohol and the liver. Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, C S Lieber. Plenum Medical Book Company, New York 1992; 185–239
- Reinke L A, Lai E K, McCay P B. Administration of ethanol or acetaldehyde to rats results in the generation of free radicals in liver, heart, and other organs. Biomedical and Social Aspects of Alcohol and Alcoholism, K Kuriyama, A Takada, H Ishii. Elsevier, Amsterdam 1988; 663–6
- Acetaldehyde. Allyl Compounds, Aldehydes, Epoxides and Peroxides. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, International Agency for Research on Cancer, Lyon 1985; 101–32
- Espina N, Lima V, Lieber C S, Garro A J. In vitro, in vivo inhibitory effect of ethanol and acetaldehyde on 06-methylguanine transferase. Carcinogenesis 1988; 9: 761–6
- Jansson T. The frequency of sister chromatid exchanges in human lymphocytes treated with ethanol and acetaldehyde. Hereditas 1982; 97: 301–3
- Obe G, Ristow H. Mutagenic, cancerogenic and teratogenic effects of alcohol. Mutat Res 1979; 65: 229–59
- Roine R P, Gentry R T, Lim R T, Jr, Baraona E, Lieber C S. Effect of concentration of ingested ethanol on blood alcohol levels. Alcohol Clin Exp Res 1991; 15: 734–8
- Gentry R T, Sharma R, Lim R T, Jr, Baraona E, DiPadova C, Lieber C S. A new method to quantify first pass metabolism of alcohol: application to the effects of H2-blockers on alcohol bioavailability (Abstract). Gastroenterology 1992; 92: A811
- Stone C L, Thomasson H R, Bosron W F, Li T-K. Purification and partial amino acid sequence of a high-activity human stomach alcohol dehydrogenase. Alcohol Clin Exp Res 1993; 17: 911–8
- Halstedt C H, Robles E A, Mezey E. Distribution of ethanol in the human gastrointestinal tract. Am J Clin Nutr 1973; 26: 831–4
- Kaihovaara P, Salmela K S, Rolne R P, Kosunen T U, Salaspuro M. Purification and characterization of Helicobacter pylori alcohol dehydrogenase. Alcohol Clin Exp Res 1994; 18: 1220–5
- Hazell S L, Evans D J, Jr, Graham D Y. Helicobacter pylori catalase. J Gen Microbiol 1991; 137: 57–61
- Seitz H K, Simanowski U A, Garzon F T, et al. Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat. Gastroenterology 1990; 98: 406–13
- Matysiak-Budnik T, Karkkainen P, Methuen T, Roine R P, Salaspuro M. Inhibition of gastric cell proliferation by acetaldehyde. J Pathol, in press
- Roine R P, Salmela K S, Itälä L, Sillanaukee P, Kaihovaara P, Salaspuro M. Gastric ethanol oxidation and acetaldehyde-protein adduct formation. A sequence leading to ethanol related gastric injury? (Abstract). Gastroenterology 1994; 106: A970
- Graham D Y, Evans D J, Jr, Evans D G. Helicobacter pylori alcohol dehydrogenase in perspective: an interesting finding of doubtful clinical significance. Scand J Gastroenterol 1994; 29: 481–2
- Spiegelhalder C, Gerstenecker B, Kersten A, Schiltz E, Kist M. Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun 1993; 61: 5315–25
- Tillonen J, Salaspuro M, Roine R. Bismuth compounds are potent inhibitors of bacterial and yeast alcohol dehydrogenase activity (Abstract). Pharmacol Toxicol 1994; 74(Suppl 1)39
- Thuluvath R, Wojno K J, Yardley J H, Mezey E. Effects of Helicobacter pylori infection and gastritis on gastric alcohol dehydrogenase activity. Alcohol Clin Exp Res 1994; 18: 795–8
- Julkunen R JK, Tannenbaum L, Baraona E, Lieber C S. First pass metabolism of ethanol: an important determinant of blood levels after alcohol consumption. Alcohol 1985; 2: 437–41
- DiPadova C, Womer T M, Julkunen R JK, Lieber C S. Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 1987; 92: 1169–73
- Egerer G, Krämer S, Leucht T, Simanowski U A, Seitz H K. Chronic atrophic gastritis results in decreased gastric alcohol dehydrogenase activity (Abstract). Alcohol Clin Exp Res 1992; 16: 606